Multiple defects of the nerve growth factor receptor in human neuroblastomas
- PMID: 1963076
Multiple defects of the nerve growth factor receptor in human neuroblastomas
Abstract
Neuroblastoma is a tumor of postganglionic sympathetic origin, and nerve growth factor (NGF) is normally required for the survival and differentiation of sympathetic neuroblasts. Since the biological activity of NGF is mediated by the NGF receptor (NGFR), we hypothesized that defects in the NGF/NGFR pathway may play a role in maintenance of the undifferentiated state of neuroblastomas. To test this hypothesis, we examined the structure of the NGFR at the DNA, RNA, and protein levels in a panel of 10 neuroblastoma cell lines. In addition, we examined the function of the NGFR in these lines by analysis of NGF binding kinetics, as well as by the ability of NGF to induce c-fos expression and neurite outgrowth. Southern blot analysis showed that all 10 cell lines possess apparently normal NGFR genes. Northern blot and ligand binding/immunoprecipitation assays revealed four receptor-positive cell lines (NGP, NLF, SK-N-SH, and LA-N-6), with NGFR mRNA and protein of expected sizes (3.8 kilobases and Mr approximately 75,000, respectively). NGF binding assays and Scatchard analyses were performed on the four NGFR-positive lines. The NGP line possesses only low-affinity receptor (Kd approximately 3.5 x 10(-9)), whereas the other three lines express both low- and high-affinity forms (Kd approximately 10(-9) and Kd approximately 10(-11), respectively). However, none of the 10 lines exhibited a response to NGF treatment as assayed by c-fos mRNA induction and neurite extension.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Multiple defects of the nerve growth factor receptor in human neuroblastomas.Prog Clin Biol Res. 1991;366:219-26. Prog Clin Biol Res. 1991. PMID: 2068140
-
Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.Prog Clin Biol Res. 1994;385:169-75. Prog Clin Biol Res. 1994. PMID: 7972209
-
Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.Cell Growth Differ. 1990 Feb;1(2):79-85. Cell Growth Differ. 1990. PMID: 1964795
-
Primitive neuroectodermal tumors (PNETs) of the CNS and PNS that express functional nerve growth factor receptors (NGFR) but fail to differentiate in response to NGF.Prog Clin Biol Res. 1991;366:243-8. Prog Clin Biol Res. 1991. PMID: 1648743 Review. No abstract available.
-
The NGF story and neuroblastoma.Med Pediatr Oncol. 1998 Aug;31(2):113-5. doi: 10.1002/(sici)1096-911x(199808)31:2<113::aid-mpo14>3.0.co;2-o. Med Pediatr Oncol. 1998. PMID: 9680939 Review.
Cited by
-
Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells.Cancer Sci. 2016 Mar;107(3):233-41. doi: 10.1111/cas.12882. Epub 2016 Feb 9. Cancer Sci. 2016. PMID: 26749374 Free PMC article.
-
Immunohistochemical detection of p140trkA and p75LNGFR neurotrophin receptors in neuroblastoma.J Neurooncol. 1997 Jan;31(1-2):57-64. doi: 10.1023/a:1005781313596. J Neurooncol. 1997. PMID: 9049831
-
The use of nerve growth factor as a reverse transforming agent for the treatment of neurogenic tumors: in vivo results.Acta Neuropathol. 1992;83(6):624-9. doi: 10.1007/BF00299412. Acta Neuropathol. 1992. PMID: 1322002
-
Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma.Sci Rep. 2019 Mar 26;9(1):5125. doi: 10.1038/s41598-019-41553-y. Sci Rep. 2019. PMID: 30914706 Free PMC article.
-
Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.Oncotarget. 2014 Nov 30;5(22):11180-92. doi: 10.18632/oncotarget.2611. Oncotarget. 2014. PMID: 25361003 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical